Identification of an AMP-activatable pyruvate dehydrogenase isozyme in embryos and tumors  by Lazo, Pedro A. & Sols, Alberto
Volume 120, number 2 FEBS LETTERS November 1980 
IDENTIFICATION OF AN AMP-ACTIVATABLE PYRUVATE DEHYDROGENASE ISOZYME 
IN EMBRYOS AND TUMORS 
Pedro A. LAZO* and Albert0 SOLS 
Instituto de Enzimologia y Patologio Molecular de1 CSIC, Facultad de Medicina, Universidad Autbnoma, Madrid 34, Spain 
Received 24 September 1980 
1. Introduction 
We have found that the pyruvate dehydrogenase of 
ascites tumor cells is activated by AMP in what appears 
to be an allosteric effect not detected in any of several 
normal tissues examined [ 11. We report now that this 
activation of a pyruvate dehydrogenase by AMP 
applies also to the enzyme in a human embryo, chick- 
en embryos and a human tumour. These observations 
suggest hat there is a fetal isozyme of pyruvate 
dehydrogenase, or at least of its decarboxylase com- 
ponent [2], that tends to appear in tumours. To our 
knowledge no information has been published on the 
occurrence of isozymes of pyruvate dehydrogenase. 
2. Materials and methods 
The human embryo, kindly supplied by Dr F. 
Ofiorbe (Ciudad Sanitaria La Paz, Madrid) was from 
an abortion of 14 weeks. Chicken embryos (14) of 
6 days (obtained from Avicola Grau, Madrid) were 
pooled; they were washed in 115 mM NaCl, 5 mM 
potassium phosphate (pH 7.4) and suspended at l/4 
(w/v) in 0.25 M sucrose, 2 mM EDTA, 5 mM /3-mer- 
captoethanol, 10 mM sodium phosphate (pH 7.4) and 
homogenized by sonication at 12 microns X 8 times 
for 5 s in a MSE sonifier; the homogenates were cen- 
trifuged at 40 000 X g for 30 min and the superna- 
tants were used for enzymatic assays. The suspension 
of cells from a case of human chronic myeloid leuke- 
mia, kindly donated by Dr L. M. Barbolla (Clinica 
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Puerta de Hierro, Madrid), had 95% abnormal mature 
cells and 5% blastic cells and the Philadelphia chro- 
mosome was positive in 90% of the cells; mitochondria 
were isolated as in [l] and homogenized with 0.5% 
Triton X-100; the mitochondrial homogenate was 
centrifuged at 40 000 X g for 30 min and the super- 
natant used for enzymatic assay. Pyruvate decar- 
boxylase activity was measured at 37°C in the pres- 
ence of 0.5 mM [ 1 -14C]pyruvafe (Radiochemical 
Centre, Amersham) with a final spec. act. of 15 kBq/ 
pmol, 0.2 mM thiamine pyrophosphate and varying 
AMPconcentrations, in the absence of CoA and NAD’, 
in a system containing 50 mM TES buffer, 100 mM 
KCI, 5 mM MgC12, 5 mM /3-mercaptoethanol (pH 7.4). 
The reaction was in a tube tightly fitted with a rubber 
cap holding a central container with 0.5 ml, of 1 M 
hyamine in methanol. The reaction was stopped after 
3 min with 1 ml 7% HC104 and allowed to stand for 
90 min to fix the 14C02. The hyamine solution was 
transferred to a vial and coi,mted for radioactivity. A 
control was run without enzyme to correct for spon- 
taneous decarboxylation of pyruvate. Protein was 
determined by the Coomassie blue method [3]. 
3. Results and discussion 
Since tumours in general have considerably less 
mitochondria than normal tissues, the likely contam- 
ination of tumour cells with normal cells in solid tumours 
would hinder the possibility of detecting an activa- 
tion of pyruvate dehydrogenase by AMP. For this 
reason we examined a case of chronic myeloid leuke- 
mia with a very high count of white cells and enrich- 
ment by leucophoresis. As shown in fig. 1 this tumotir 
proved to have an AMP-activatable enzyme. We then 
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Fig.1. AMP activation of the pyruvate decarboxylase activity 
of the pyruvate dehydrogenase complex from human (0) and 
chicken (A) embryos and human chronic myeloid leukemia 
(0). Activities are expressed in nmol . min-’ . mg protein-‘, 
X 10 for the human embryo, and Xl00 for the chicken 
embryo. 
examined some embryos, following the clue that in 
several cases of enzymes for which a fetal isozyme is 
known, it frequently appears also in tumours [4]. Both 
a 3-month-old human embryo from accidental abor- 
tion and a pool of 6-day-old chicken embryos also 
gave activation of pyruvate dehydrogenase by AMP 
(fig.1). 
The maximal activation by AMP achieved, cal- 
culated from the data shown in fig.1, using a double 
reciprocal plot of l/AMP vs l/v, - v,were 2.5-,2.9- 
and 3.0-fold for chicken and human embryos and the 
leukemia cells respectively, with K, values of 10, 15 
and 18 PM. For the ascites tumour we had obtained a 
maximal activation of -2.0 and a K, of 40 /AM [ 11. 
On the whole it seems that maximal activation of the 
new isozyme by AMP is -2-3-fold with a K, of 
-20 pM (within a factor of 2). 
Some cases of congenital lactic acidosis in children 
have been shown to involve a deficiency in the pyruvate 
decarboxylase component of pyruvate dehydrogenase 
[S-8]. In a case of complete deficiency [6] the infant, 
born premature (8 months, 1.3 kg), showed rapid 
respiration during the first days of life and died at 
6 months despite treatment to lower the elevated 
lactic acid in serum. It can be speculated that intra- 
uterine development in cases of congenital deficiency 
of pyruvate decarboxylase could initially proceed 
unimpaired because of the fetal isozyme; it will be 
interesting to ascertain the timing of the shift from 
fetal to adult isozyme for pyruvate decarboxylase in 
humans. 
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